AstraZeneca Signs $700 Million Cancer Drug Deal with Inovio


AstraZeneca is going places. The large corporation has settled its cancer drug project. Now it has sole rights over an immune boosting medicine which it bought from Inovio. Inovio gets $27.5 million...

eHorizon brings vehicle tech to CES 2015


Continental, the company that specializes in smart technologies for transportation vehicles, has announced that they will be at the International Consumer Electronics Show, aka CES 2015, and that...